title: [Consensus document on spasticity in patients with multiple sclerosis. Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología].
abstract: BACKGROUND
  Multiple sclerosis is a chronic neurological inflammatory demyelinating disease. Specialists involved in the symptomatic treatment of this disease tend to apply heterogeneous diagnostic and treatment criteria.
  
  
  OBJECTIVE
  To establish homogeneous criteria for treating spasticity based on available scientific knowledge, facilitating decision-making in regular clinical practice.
  
  
  METHODS
  A group of multiple sclerosis specialists from the Spanish Neurological Society demyelinating diseases working group met to review aspects related to spasticity in this disease and draw up the consensus. After an exhaustive bibliographic search and following a metaplan technique, a number of preliminary recommendations were established to incorporate into the document. Finally, each argument was classified depending on the degree of recommendation according to the SIGN (Scottish Intercollegiate Guidelines Network) system. The resulting text was submitted for review by the demyelinating disease group. An experts' consensus was reached regarding spasticity triggering factors, related symptoms, diagnostic criteria, assessment methods, quality of life and therapeutic management (drug and non-drug) criteria.
  
  
  CONCLUSIONS
  The recommendations included in this consensus can be a useful tool for improving the quality of life of multiple sclerosis patients, as they enable improved diagnosis and treatment of spasticity.
authors.affiliation: Hospital Clinico San Carlos, 28040 Madrid, Espana.
authors.forename: Celia
authors.initials: C
authors.lastname: Oreja-Guevara
authors.forename: Xavier
authors.initials: X
authors.lastname: Montalban
authors.forename: Clara
authors.initials: C
authors.lastname: de Andrés
authors.forename: Bonaventura
authors.initials: B
authors.lastname: Casanova-Estruch
authors.forename: Delicias
authors.initials: D
authors.lastname: Muñoz-García
authors.forename: Inmaculada
authors.initials: I
authors.lastname: García
authors.forename: Óscar
authors.initials: Ó
authors.lastname: Fernández
mesh_terms: D000465:Algorithms; D003286:Contracture / Q000209:etiology / Q000517:prevention & control; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D009128:Muscle Spasticity / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000534:rehabilitation; D009788:Occupational Therapy; D009983:Orthopedic Equipment; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D011788:Quality of Life; D012720:Severity of Illness Index
chemical_list: D010276:Parasympatholytics